INTRODUCTION
The activation of adenylate cyclase by f,-adrenergic-receptor agonists involves the interactions of ,-agonist with receptor, receptor with GS, and of Gsca with adenylate cyclase. The functioning of this pathway depends on both the affinities and the rates of these interactions, as well as the relative abundance of these components in the cell membrane. It is well known that changes in receptor affinity for agonist and in agonist concentration play an important role in receptor-mediated secondmessenger production [1] [2] [3] . However, the extent to which the relative stoichiometry of receptor, G-protein and effector regulates signal transduction is not well understood. Previous work has demonstrated that, in the presence of ,I-adrenergic-receptor agonists, an excess of Gsa, from several-fold to as high as 100-fold, can be activated in response to the activation of a single receptor molecule [4] [5] [6] [7] . Because of this ability of a single receptor to activate many G-protein molecules, and considering the excess of G,a relative to the amount of ,3-adrenergic receptor [8, 9] , one might expect that adenylate cyclase would in turn be present in equal or greater amounts than the Gsa protein to maintain this signal amplification. Although limited studies in continuous cell lines suggest that this is not the case [10] [11] [12] , these cultured cell lines are often derived from transformed cells and may not accurately reflect the situation in a physiologically normal cell. Indeed, tumorigenic growth has been associated with elevated G,a protein expression [13, 14] . Information about the ratio between signalling proteins in native cells is lacking.
We have studied the stoichiometry of proteins involved in the /8-adrenergic response of isolated adult rat cardiac myocytes. We have utilized quantitative immunoblots to quantify G,a protein addition of isoprenaline (isoproterenol) and guanosine 5'-[ythio]trisphosphate to saponin-permeabilized myocytes results in the formation of 6 x 105 Gsa-adenylate cyclase complexes.
Taken together, the data presented here demonstrate that, in a physiologically relevant setting, G-protein is present in large stoichiometric excess relative to both receptor and effector. In addition, we show that, overall, only modest signal amplification occurs between receptor and adenylate cyclase. Thus adenylate cyclase (rather than G.) is the component distal to receptor that limits agonist-mediated increases in cyclic AMP production. Although limited data are as yet available for other G-proteinregulated effectors, we hypothesize that the stoichiometry of signalling components and the extent of signal amplification described for the /8-adrenergic response pathway will be applicable to other G-protein-coupled hormone receptor systems.
and [3H]forskolin-binding assays to quantify Gsa-adenylate cyclase complex formation. Forskolin-binding assays take advantage of the increased affinity of forskolin interaction with adenylate cyclase in the presence of G,a-GTP [10, 12] . This assay therefore provides a measure of Gsa-adenylate cyclase interaction that is independent of second-messenger production. Determination of the relative stoichiometry of proteins in the ,-adrenergic-response pathway in cardiac myocytes is particularly important in that these cells represent a physiologically relevant setting and because the ratio of these proteins is thought to be of critical importance for normal cardiac function [14, 15] . Indeed, recent evidence suggests that cardiac function may be regulated, in part, by altering the membrane content of various components of the f,-adrenergic-receptor-adenylate cyclase signal-transduction pathway [15] [16] [17] . Isolation and permeabilization of cardiac myocytes Ventricular myocytes from 250-300 g adult Sprague-Dawley rats were isolated by collagenase digestion as described previously [18] . Briefly, rat hearts were perfused at 32°C for 45 min with minimum essential medium (MEM) containing 0.1 % collagenase (Boehringer-Mannheim), 0.1 % BSA and 25,M Ca2+. After removal of the atria, the ventricles were cut into pieces and myocytes dispersed by gentle agitation through a wide-bore serologic pipette. The cells were filtered through a nylon mesh and washed twice by centrifugation (50 g). The cell pellet was suspended in MEM containing 0.1 % BSA and Ca2+ (added slowly to a final concentration of 1 mM). The preparation typically provided (10) (11) (12) (13) (14) (15) x 106 myocytes per heart, with 80% viability as assessed by rod-shaped morphology and exclusion of Trypan Blue.
For experiments involving permeabilized cells, isolated myocytes were pelleted by centrifugation (200 g) and resuspended in 'reverse' buffer (100 mM KCI, 20 mM NaCl, 1 mM NaH2PO4, 
Quantification of G.0x
Isolated rat ventricular myocytes were pelleted by centrifugation; the media were aspirated, and cells were frozen and stored at -80 'C. Frozen cells were powdered with a stainless-steel mortar and pestle (also at -80 'C), suspended in buffer (10 mM Tris, 5 mM MgSO4, 5 ,ug/ml pepstatin, 10 ,ug/ml benzamidine, 10 ug/ml leupeptin, 100 ,ug/ml PMSF; pH 7.4), and homogenized in a glass/glass vessel. Crude cellular membranes were isolated by centrifugation (13 300 g) for 10 min at 4 'C. Protein concentration was determined by the Bradford protein assay [19] . Proteins from three different cardiac myocyte membrane preparations were subjected to SDS/PAGE (10% separating gel) and electroblotted on to a poly(vinylidene difluoride) (PVDF; Immobilon-P) membrane. A bacterially expressed fusion protein consisting of glutathione S-transferase (GST) fused to the Cterminus of G,a, purified on a glutathione affinity column, was used to generate a standard curve for quantification. Nonspecific antibody binding was blocked by incubating membranes in 5 % BSA for 1 h at 25 'C, and G,a was detected by using affinity-purified Gsa-specific polyclonal antisera. Detection of primary antibody was accomplished by incubating membranes with horseradish peroxidase coupled to anti-rabbit IgG for 30 min at 25 'C. After the addition ofchemiluminescent substrate (ECL, Amersham), blots were exposed to film for 0.5-3 min and band intensity was determined by densitometric analysis.
Cyclic AMP assays Equilibrated suspensions of intact myocytes (2 x IO' cells/ml) were treated with agonists for 4 min at 32 'C, after which cold trichloroacetic acid (10 % final concn.) was added. The samples were centrifuged at 1200 g for 15 min and the trichloroacetic acid Cyclic AMP content was determined by the protein-binding method ofGilman [20] . Acid-precipitable material was suspended in 0.4 M NaOH and the protein content determined by the method of Bradford [19] . Data are expressed as pmol of cyclic AMP (corrected for recovery over Dowex columns) per 2 x 105 cells.
[3H]Forskolin-blnding assays
[3H]Forskolin-binding assays were conducted by a modification of published methods [10, 12] . Permeabilized or intact cells (1 x 105) were incubated in 'reverse' buffer or Dulbecco's MEM supplemented with 20 mM Hepes (DMEH) respectively, with 20 nM [3H]forskolin and the additions indicated in the Figure legends in a total volume of 0.5 ml for 10 min at 25 'C. Reactions were terminated by the addition of ice-cold wash buffer (50 mM Tris, 10 mM MgCl2; pH 7.4) and the rapid filtration of cells on Whatman GF/C filters using a Brandel cell harvester. Filters were washed with 10 ml of wash buffer and radioactivity associated with cells was determined by scintillation counting of filters. Under these filtration conditions less than 5 % ofbound forskolin dissociates in 5 min after dilution of cell suspensions; therefore, dissociation of bound forskolin in the 30-60 s wash period is negligible.
RESULTS

G1oc quantmficatlion
The amount of G,a in cells has been quantified both by choleratoxin-mediated ADP-ribosylation using labelled substrate and by quantitative immunoblotting [17, [21] [22] [23] . Values obtained by toxin labelling are typically much lower than those obtained by immunoblots of G-protein in the same cells [17, 23] . Whether this reflects a population of G,a that is not a substrate for cholera toxin, or whether it is an inherent problem with this indirect method of quantification, is unclear. Therefore, we determined G,a levels in cardiac myocytes by quantitative immunoblotting using an affinity-purified G,a-specific antibody and an affinitypurified GST-G,a fusion protein (containing the epitope used to generate the anti-G,a antibody) as a standard for quantification [17] . Membrane proteins prepared from three different ventricular myocyte isolations were separated by SDS/PAGE. Various amounts of the GST-Gsa protein were included to generate a standard curve. Myocyte membranes contain both 52 kDa and 45 kDa forms of G,a in the ratio 1:3 ( Figure la) [10, 12, 24] . Quantification using changes in enzyme activity is complicated by the complex regulatory mechanisms governing adenylate cyclase activity and second-messenger generation. Therefore we utilized [3H]forskolin binding to extracts were purified over Dowex AG50W X4 (200-400 mesh). quantify adenylate cyclase. The synergistic enhancement of adenylate cyclase activity and formation of high-affinity forskolin-binding sites by either receptor-or cholera-toxin-induced activation of G,a indicates that the interaction of forskolin with adenylate cyclase is greatly enhanced by functional Gsa [10, 12, [24] [25] [26] . As shown in Table 1 , forskolin and isoprenaline each increased intracellular cyclic AMP in isolated myocytes. Importantly, when these agents were added together, cyclic AMP generation was up to 50 times greater than with either agent alone. This result is consistent with the G,a-dependent enhancement of forskolin-adenylate cyclase interaction observed in other cell systems. adrenergic receptors per myocyte, primarily of the 31 subtype, observed in radioligand binding studies [29, 30] .
DISCUSSION
An important concept in signal transduction is amplification, whereby one receptor promotes the activation of many effector molecules. The hypothesis that signal amplification results, in part, via interaction of a single receptor with multiple molecules of a particular G-protein is supported by numerous observations [4] [5] [6] [7] [8] [9] , including the large excess of G-proteins relative to receptor. The idea that amplification might also occur between G-proteins and effector molecules has not been well studied, but for hormonal systems is not well supported by the limited data currently available. In the instance of rhodopsin-transducin, a photon of light activates a single rhodopsin molecule, which, in turn, activates up to 500 transducin molecules and thereby a roughly equivalent number of phosphodiesterase molecules [31, 32] . By contrast with the rhodopsin system, agonist binding to isolated cardiac myocytes (the present paper) and cultured cells [10, 12] [10] . Third, Gsa binding to Types V and VI adenylate cyclase over-expressed in Sf9 cell membranes is enhanced in the presence of forskolin [37] . Fourth, as reported recently, Types II, V and VI adenylate cyclase demonstrate enhanced forskolin binding in the presence of GsX; Type I adenylate cyclase binds forskolin with high affinity even in the absence of G,a [38] . Types IV and VII adenylate cyclase have been detected in heart tissue [39, 40] , but substantial quantities are not likely to be present in isolated myocytes, since Type IV mRNA is only detectable in myocardial preparations by polymerase chain reaction. Also, the activity of Type VII is increased by phorbol ester; but we do not observe an enhancement of cyclic AMP production by phorbol esters (results not shown). Therefore, it would seem unlikely that we have substantially underestimated the number of adenylate cyclase complexes present in cardiac myocytes.
Since previous data indicate that each cardiac myocyte has about 2.1 x 105 ,-adrenergic receptors, overall there appears to be about a 3-fold amplification of signal between receptor and effector. In contrast, the amount of cyclic AMP produced in response to isoprenaline and forskolin treatment (Table 1) is in great excess relative to fl-receptor. Therefore, amplification of the primary signal (hormone binding) observed by measuring cyclic AMP production arises primarily from the enzymic activity of adenylate cyclase, but not from the activation of a large number of adenylate cyclase molecules.
The biological utility of such a large excess of G,a relative to receptor and effector is not obvious. One explanation is that G,a couples to large quantities of many types of receptors (as yet unknown) and to effectors other than adenylate cyclase. To our knowledge, L-type Ca2l and Na+ channels are the only effectors other than adenylate cyclase shown to interact with cardiac G,a [41, 42] . In cardiac myocytes, adenylate cyclase, Na+ channels and Ca2l channels are present in similar amounts and together are much less abundant than G,a (the present paper; [43] [44] [45] ). Alternatively, although Gsa is in great stoichiometric excess relative to f,-adrenergic receptors and adenylate cyclase, it may not be in functional excess. Potentially, (a) Gsac has a relatively low affinity for adenylate cyclase, such that activated G,a must be present in great amounts in order to achieve high levels of intracellular cyclic AMP, (b) the relative abundance of Gsa ensures specific coupling of fi-adrenergic receptor with adenylate cyclase, (c) excess Gsa may increase the rate and duration of the adenylate cyclase response, or (d) the Gsa interaction with receptor and effector may be physically constrained by compartmentation or by cytoskeletal associations, as has been recently postulated [46] . That Gac is in functional excess is supported by the observation that myocardial membranes prepared from transgenic mice overexpressing G,a protein demonstrated no difference in basal or stimulated (GTP + isoprenaline, NaF, or forskolin) adenylate cyclase activity relative to control myocardial membranes [47] . It will be important to assess receptoreffector coupling in cells where the expression of individual components of the f8-adrenergic-receptor-adenylate cyclase signal-transduction pathway has been altered.
Overall, the results presented here demonstrate that in a physiological setting Gsa is in great excess relative to either receptor or effector. In addition, we show that substantial amplification of the primary signal (hormone binding) does not occur between receptor and effector, in that receptor occupancy results in the activation of only a modestly greater number of adenylate cyclase molecules than of receptors. The amplification of second messenger relative to f8-adrenergic receptor seems to arise from the enzymic activity of adenylate cyclase. Thus it appears that effector (adenylate cyclase) is likely to be the most limiting factor for maximal hormone-mediated cyclic AMP production. We hypothesize that the stoichiometry observed for
